Abstract 425: Overcoming PARP inhibitor resistance in triple-negative breast cancer models through olaparib and RAD51 inhibition with TGF-beta 2 downregulation
Year: 2025
Type: conference-abstract
Source: Cancer Research
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409689954
